AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16919803 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-delivered HIV/AIDS risk reduction intervention
Number of subjects: 157
Study 16919803 — intervention group
Group type: COMPARATOR
Intervention: Nutrition education tutorial (Control)
Number of subjects: 157
Study 14510798 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 60
Study 14510798 — intervention group
Group type: COMPARATOR
Intervention: Toremifene
Number of subjects: 60
Study 11012559 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg at 40 degrees C
Number of subjects: 12
Study 11012559 — intervention group
Group type: COMPARATOR
Intervention: Placebo at 40 degrees C
Number of subjects: 12
Study 11012559 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg at 22 degrees C
Number of subjects: 12
Study 11012559 — intervention group
Group type: COMPARATOR
Intervention: Placebo at 22 degrees C
Number of subjects: 12
Study 8960444 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 0
Study 8960444 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study 8960444 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 0
Study 8960444 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitors
Number of subjects: 0
Study 8960444 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 0
Study 8960444 — intervention group
Group type: COMPARATOR
Intervention: Nitrates
Number of subjects: 0
Study 8960444 — intervention group
Group type: COMPARATOR
Intervention: Class I antiarrhythmic agents
Number of subjects: 0
Study 8960444 — intervention group
Group type: COMPARATOR
Intervention: Magnesium
Number of subjects: 0
Study 8960444 — intervention group
Group type: COMPARATOR
Intervention: Calcium antagonists
Number of subjects: 0
Study 1577361 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg haloperidol/day for 14 days
Number of subjects: 90
Study 1577361 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg haloperidol/day for 14 days
Number of subjects: 90
Study 1577361 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually matched haloperidol dosage for 14 days
Number of subjects: 90
Study 1577361 — intervention group
Group type: COMPARATOR
Intervention: Fixed doses (10 mg and 20 mg haloperidol)
Number of subjects: 90
Study 3883868 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-dose total lymphoid irradiation (2000 rad)
Number of subjects: 26
Study 3883868 — intervention group
Group type: COMPARATOR
Intervention: Low-dose total lymphoid irradiation (200 rad)
Number of subjects: 26
Study 31108842 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) for 8 weeks, combined with standard swimming training (8 times a week)
Number of subjects: 16
Study 31108842 — intervention group
Group type: COMPARATOR
Intervention: Standard Swimming Training (ST) for 8 weeks, without additional IMT
Number of subjects: 16
Study 28782541 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based transfer training module
Number of subjects: 71
Study 28782541 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person transfer training session
Number of subjects: 71
Study 28782541 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (WLCG)
Number of subjects: 71
Study 26402923 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg testosterone
Number of subjects: 18
Study 26402923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 24363302 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitrite 40 mg
Number of subjects: 55
Study 24363302 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitrite 80 mg
Number of subjects: 55
Study 24363302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 22367259 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored physical activity program
Number of subjects: 0
Study 20487122 — intervention group
Group type: EXPERIMENTAL
Intervention: RVOT pacing
Number of subjects: 58
Study 20487122 — intervention group
Group type: COMPARATOR
Intervention: RVA pacing
Number of subjects: 58
Study 19009805 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermia applied to the head or entire body, maintaining a temperature of 33-34 degrees C for 72 hours, started within 6 hours after birth.
Number of subjects: 200
Study 16208798 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral‐B ProfessionalCare 7000 (PC 7000)
Number of subjects: 79
Study 16208798 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral‐B 3D Excel (3DE)
Number of subjects: 79
Study 16208798 — intervention group
Group type: COMPARATOR
Intervention: Sonicare Advance (SA)
Number of subjects: 79
Study 12504934 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of 300 microg of Rhophylac
Number of subjects: 14
Study 12504934 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular administration of 300 microg of Rhophylac
Number of subjects: 14
Study 10900538 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol generic products (500 mg tablets)
Number of subjects: 12
Study 10900538 — intervention group
Group type: COMPARATOR
Intervention: Tylenol (reference product)
Number of subjects: 12
Study 8858742 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily
Number of subjects: 175
Study 8858742 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study 1516462 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefetamet pivoxil 10 mg/kg b.i.d.
Number of subjects: 30
Study 1516462 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefetamet pivoxil 20 mg/kg b.i.d.
Number of subjects: 30
Study 1516462 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor 10 mg/kg t.i.d.
Number of subjects: 30
Study 6373153 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcrystalline hydroxyapatite compound (MCHC) 6 to 8 g for 12 months
Number of subjects: 40
Study 6373153 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 40
Study 30974188 — intervention group
Group type: EXPERIMENTAL
Intervention: HCO-CVVHD
Number of subjects: 35
Study 28366816 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light exposure (1200lx) at varying room temperatures (26, 29, 32°C)
Number of subjects: 0
Study 28366816 — intervention group
Group type: COMPARATOR
Intervention: Dim light exposure (5lx) at varying room temperatures (26, 29, 32°C)
Number of subjects: 0
Study 28366816 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower room temperature (26, 29, 32°C)
Number of subjects: 0
Study 27170563 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention (one face-to-face dietitian consultation, followed by phone reviews)
Number of subjects: 217
Study 27170563 — intervention group
Group type: COMPARATOR
Intervention: Control group (BOS database)
Number of subjects: 217
Study 27170563 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention group
Number of subjects: 217
Study 27170563 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 217
Study 24727160 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly 56.5 μg teriparatide for 72 weeks
Number of subjects: 209
Study 24727160 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study 22621829 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG-primed (10,000 IU)
Number of subjects: 82
Study 22621829 — intervention group
Group type: COMPARATOR
Intervention: Non-primed
Number of subjects: 82
Study 21058604 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-talk intervention (self-determined instructional cue words)
Number of subjects: 16
Study 21058604 — intervention group
Group type: COMPARATOR
Intervention: Control group (no self-talk intervention)
Number of subjects: 16
Study 17402960 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology for 30 minutes
Number of subjects: 9
Study 17402960 — intervention group
Group type: COMPARATOR
Intervention: Control group resting for 30 minutes
Number of subjects: 9
Study 16336019 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole
Number of subjects: 301
Study 16336019 — intervention group
Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 301
Study 11677105 — intervention group
Group type: EXPERIMENTAL
Intervention: One course of perioperative polychemotherapy (anthracycline-containing regimen within 36 hours after surgery)
Number of subjects: 2795
Study 11677105 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 2795
Study 9625243 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey dressing
Number of subjects: 50
Study 9625243 — intervention group
Group type: COMPARATOR
Intervention: Silver sulfadiazine (SSD)
Number of subjects: 50
Study 7606631 — intervention group
Group type: EXPERIMENTAL
Intervention: Submaximal exercise test for 30 min at 60% of individual maximal work capacity
Number of subjects: 16
Study 7606631 — intervention group
Group type: COMPARATOR
Intervention: Resting condition
Number of subjects: 16
Study 3554627 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal suspension (105 g)
Number of subjects: 6
Study 3554627 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorbitol-charcoal suspension (105 g)
Number of subjects: 6
Study 3554627 — intervention group
Group type: COMPARATOR
Intervention: Phenobarbital i.v. alone
Number of subjects: 6
Study 30625492 — intervention group
Group type: EXPERIMENTAL
Intervention: Left thalamic stimulation
Number of subjects: 7
Study 30625492 — intervention group
Group type: EXPERIMENTAL
Intervention: Right thalamic stimulation
Number of subjects: 7
Study 30625492 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral thalamic stimulation (Bil-ON)
Number of subjects: 7
Study 30625492 — intervention group
Group type: COMPARATOR
Intervention: No stimulation (Bil-OFF)
Number of subjects: 7
Study 30625492 — intervention group
Group type: COMPARATOR
Intervention: Unilateral nondominant stimulation
Number of subjects: 7
Study 28025642 — intervention group
Group type: EXPERIMENTAL
Intervention: Short duration small sided football (FG15)
Number of subjects: 56
Study 28025642 — intervention group
Group type: EXPERIMENTAL
Intervention: Long duration small sided football (FG60)
Number of subjects: 56
Study 28025642 — intervention group
Group type: COMPARATOR
Intervention: Low magnitude whole body vibration (VIB)
Number of subjects: 56
Study 24911260 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavior therapy (ICBT)
Number of subjects: 90
Study 24911260 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 90
Study 23910201 — intervention group
Group type: EXPERIMENTAL
Intervention: Loaded miniscrew implants
Number of subjects: 36
Study 23910201 — intervention group
Group type: COMPARATOR
Intervention: Unloaded miniscrew implants
Number of subjects: 36
Study 21208128 — intervention group
Group type: EXPERIMENTAL
Intervention: Bed of nails (BN)
Number of subjects: 32
Study 21208128 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxing instructions and music
Number of subjects: 32
Study 21208128 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxing instructions
Number of subjects: 32
Study 17933452 — intervention group
Group type: COMPARATOR
Intervention: Dopamine
Number of subjects: 151
Study 17933452 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous pacing (TCP)
Number of subjects: 151
Study 16502744 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS group (electrical stimulation of the wrist and finger extensors for 1 h/day in addition to neurodevelopmental exercises)
Number of subjects: 36
Study 16502744 — intervention group
Group type: COMPARATOR
Intervention: Control group (neurodevelopmental exercises only for 1 h/day)
Number of subjects: 36
Study 16502744 — intervention group
Group type: COMPARATOR
Intervention: Both groups (TENS and control)
Number of subjects: 36
Study 14505201 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruby laser treatment (3 treatments given at monthly intervals)
Number of subjects: 69
Study 10872958 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline treatment (8.5% sustained-release biodegradable gel)
Number of subjects: 45
Study 10872958 — intervention group
Group type: COMPARATOR
Intervention: Oral hygiene instruction/reinforcement (Control)
Number of subjects: 45
Study 9331117 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2 plus carboplatin (AUC 6)
Number of subjects: 49
Study 9331117 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel 225 mg/m2 plus carboplatin (AUC 6)
Number of subjects: 49
Study 7963760 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized radiation treatment (1.8 Gy per fraction, 17 fractions)
Number of subjects: 15
Study 7963760 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized radiation treatment
Number of subjects: 15
Study 6620012 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone, head-elevated positioning in a harness
Number of subjects: 15
Study 6620012 — intervention group
Group type: COMPARATOR
Intervention: Infant seat
Number of subjects: 15
Study 30449208 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625 mg of conjugated equine estrogen (CEE) and 100 mg of micronized progesterone (MP)
Number of subjects: 123
Study 30449208 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg of CEE and 100 mg of MP
Number of subjects: 123
Study 30449208 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625 mg of CEE and 10 mg of dydrogesterone (DDG)
Number of subjects: 123
Study 30449208 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 123
Study 30056419 — intervention group
Group type: EXPERIMENTAL
Intervention: Coconut oil enriched Mediterranean diet for 21 days
Number of subjects: 44
Study 30056419 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 26765495 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports bras (six randomly assigned breast support levels)
Number of subjects: 17
Study 26765495 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual questionnaire (bra comfort, bra fit, breast pain)
Number of subjects: 17
Study 25123116 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG and HA (Group B)
Number of subjects: 30
Study 25123116 — intervention group
Group type: COMPARATOR
Intervention: BCG only (Group A)
Number of subjects: 30
Study 23634562 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS (Transcutaneous nerve stimulation) preincisionally and postoperatively
Number of subjects: 35
Study 23634562 — intervention group
Group type: COMPARATOR
Intervention: Piritramide intravenously (i.v.) by patient-controlled analgesia pump
Number of subjects: 35
Study 19430254 — intervention group
Group type: EXPERIMENTAL
Intervention: IMPACT program
Number of subjects: 269
Study 19430254 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 269
Study 18051206 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray
Number of subjects: 0
Study 18051206 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine plus nasal corticosteroids
Number of subjects: 0
Study 18051206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16512751 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% alcohol-free chlorhexidine mouthrinse used twice per day for 1 week
Number of subjects: 0
Study 16512751 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthrinse used twice per day for 1 week
Number of subjects: 0
Study 15464329 — intervention group
Group type: EXPERIMENTAL
Intervention: Silzone‐coated prosthetic valve
Number of subjects: 575
Study 15464329 — intervention group
Group type: COMPARATOR
Intervention: Conventional prosthetic valve
Number of subjects: 575
Study 11214093 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical regimen (CQ for 3 days, followed by primaquine for 14 days)
Number of subjects: 79
Study 11214093 — intervention group
Group type: EXPERIMENTAL
Intervention: Short regimen (CQ and primaquine given simultaneously for 5 days)
Number of subjects: 79
Study 8984313 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized compression technique with a novel compression device, pressure of 40 to 45 mmHg, duration not specified.
Number of subjects: 0
Study 8984313 — intervention group
Group type: COMPARATOR
Intervention: Manual compression and conventional pressure dressing, duration not specified.
Number of subjects: 0
Study 8984313 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ultrasound-guided compression therapy for pseudoaneurysms, duration not specified.
Number of subjects: 0
Study 1856917 — intervention group
Group type: EXPERIMENTAL
Intervention: Eutectic mixture of local anesthetics (25 mg lidocaine and 25 mg prilocaine per gm)
Number of subjects: 83
Study 1856917 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 6349654 — intervention group
Group type: EXPERIMENTAL
Intervention: Meclofenamate sodium (300 mg per day for one week)
Number of subjects: 130
Study 6349654 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxyphenbutazone (600 mg per day)
Number of subjects: 130
Study 6349654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 31471234 — intervention group
Group type: EXPERIMENTAL
Intervention: max-pre-SD
Number of subjects: 309
Study 31471234 — intervention group
Group type: COMPARATOR
Intervention: post-SD
Number of subjects: 309
Study 31711451 — intervention group
Group type: EXPERIMENTAL
Intervention: ROP1.3 group (1.3 mL/kg of 0.15% ropivacaine)
Number of subjects: 96
Study 31711451 — intervention group
Group type: COMPARATOR
Intervention: ROP1.0 group (1.0 mL/kg of 0.15% ropivacaine)
Number of subjects: 96
Study 31711451 — intervention group
Group type: COMPARATOR
Intervention: Non-caudal block group
Number of subjects: 96
Study 28957818 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg epilutein and 2 mg lutein (group 1)
Number of subjects: 40
Study 28957818 — intervention group
Group type: COMPARATOR
Intervention: 10 mg lutein (group 2)
Number of subjects: 40
Study 24133005 — intervention group
Group type: EXPERIMENTAL
Intervention: OTG3% 84 mg/day
Number of subjects: 626
Study 24133005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 626
Study 25226730 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic scalpel (HS)
Number of subjects: 92
Study 25226730 — intervention group
Group type: COMPARATOR
Intervention: Mono-polar diathermy (electro-cautery)
Number of subjects: 92
Study 21668987 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency department patient throughput times
Number of subjects: 6
Study 21668987 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient inflow patterns
Number of subjects: 6
Study 21668987 — intervention group
Group type: EXPERIMENTAL
Intervention: Diurnal variation in throughput times
Number of subjects: 6
Study 18645727 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled furosemide (4 ml equal to 40 mg in 10 min)
Number of subjects: 41
Study 18645727 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4 ml of 0.9% saline solution)
Number of subjects: 41
Study 16842467 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg, rifabutin 150 mg and amoxicillin 1 g, each given b.d. for 7 days (ERA)
Number of subjects: 145
Study 16842467 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 40 mg and amoxicillin 1000 mg, each given t.d.s. for 14 days (OA)
Number of subjects: 145
Study 12802757 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-alpha-2a 6 MU 3 times per week for 24 weeks, then 3 MU 3 times per week for 24 weeks (group A)
Number of subjects: 68
Study 12802757 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-alpha-2a 9 MU per day for 2 weeks, then 3 MU per day for 22 weeks, then 3 MU 3 times per week for 24 weeks (group B)
Number of subjects: 68
Study 10858178 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 295
Study 8682978 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants
Number of subjects: 103
Study 8682978 — intervention group
Group type: EXPERIMENTAL
Intervention: History of conduct disorder
Number of subjects: 103
Study 8682978 — intervention group
Group type: COMPARATOR
Intervention: No history of conduct disorder
Number of subjects: 103
Study 1641524 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestriol 3 mg p.o. per day for 4 weeks, followed by 1 mg per day for 8 weeks
Number of subjects: 40
Study 1641524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 6361789 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprofen 200 mg
Number of subjects: 157
Study 6361789 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprofen 400 mg
Number of subjects: 157
Study 6361789 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg plus codeine 60 mg
Number of subjects: 157
Study 6361789 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg
Number of subjects: 157
Study 6361789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study 31900167 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer coaching intervention for the WHO Safe Childbirth Checklist
Number of subjects: 570
Study 30763195 — intervention group
Group type: EXPERIMENTAL
Intervention: Decolonization (chlorhexidine mouthwash, baths or showers with chlorhexidine, and nasal mupirocin for 5 days twice per month for 6 months)
Number of subjects: 2121
Study 30763195 — intervention group
Group type: COMPARATOR
Intervention: Education alone
Number of subjects: 2121
Study 30763195 — intervention group
Group type: EXPERIMENTAL
Intervention: Decolonization
Number of subjects: 2121
Study 30763195 — intervention group
Group type: EXPERIMENTAL
Intervention: Decolonization (adhering fully to regimen)
Number of subjects: 2121
Study 28933607 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitii™ (20 weeks of training)
Number of subjects: 60
Study 28933607 — intervention group
Group type: COMPARATOR
Intervention: Care As Usual (waitlist control; n=30)
Number of subjects: 60
Study 27184521 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic review + social interaction
Number of subjects: 273
Study 27184521 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic review + exercise
Number of subjects: 273
Study 27184521 — intervention group
Group type: COMPARATOR
Intervention: Antipsychotic review alone
Number of subjects: 273